Sodium–glucose cotransporter 2 inhibitors in type 2 diabetes patients with renal function impairment slow the annual renal function decline, in a real clinical practice

AIMS/INTRODUCTION: The aim of this study was to elucidate whether sodium–glucose cotransporter 2 inhibitors (SGLT2is) treatment has any renoprotective effect for type 2 diabetes mellitus patients with an estimated glomerular filtration rate (eGFR) of <60 mL/min/1.73 m(2) in clinical practice. MAT...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirai, Taro, Kitada, Munehiro, Monno, Itaru, Oda, Erina, Hayashi, Yoshihiro, Shimada, Keiji, Takagaki, Yuta, Ogura, Yoshio, Fujii, Mizue, Konishi, Kazunori, Sakurai, Masaru, Nakagawa, Atsushi, Koya, Daisuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409862/
https://www.ncbi.nlm.nih.gov/pubmed/33417741
http://dx.doi.org/10.1111/jdi.13502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409862/
https://www.ncbi.nlm.nih.gov/pubmed/33417741
http://dx.doi.org/10.1111/jdi.13502

Ejemplares similares